Immunology of psoriasis.
暂无分享,去创建一个
Mayte Suárez-Fariñas | James G Krueger | M. Suárez-Fariñas | J. Krueger | M. Lowes | Michelle A Lowes
[1] S. Miltenyi,et al. BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood , 2000, The Journal of Immunology.
[2] M. Blumenberg. SKINOMICS: Transcriptional Profiling in Dermatology and Skin Biology , 2012, Current genomics.
[3] A. Bruce,et al. Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis , 2011, The Journal of Immunology.
[4] Pui-Yan Kwok,et al. A Genetic Risk Score Combining Ten Psoriasis Risk Loci Improves Disease Prediction , 2011, PloS one.
[5] K. Kabashima,et al. Skin as a peripheral lymphoid organ: revisiting the concept of skin-associated lymphoid tissues. , 2011, The Journal of investigative dermatology.
[6] James T. Elder. PSORS1: linking genetics and immunology. , 2006, The Journal of investigative dermatology.
[7] Frank O. Nestle,et al. Mechanisms of Disease: Psoriasis. , 2009 .
[8] M. Gilliet,et al. Antimicrobial peptides and self-DNA in autoimmune skin inflammation. , 2008, Current opinion in immunology.
[9] Jun Yan,et al. New insights of T cells in the pathogenesis of psoriasis , 2012, Cellular and Molecular Immunology.
[10] S. Stevens,et al. Dysfunctional Blood and Target Tissue CD4+CD25high Regulatory T Cells in Psoriasis: Mechanism Underlying Unrestrained Pathogenic Effector T Cell Proliferation1 , 2005, The Journal of Immunology.
[11] Mayte Suárez-Fariñas,et al. Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis , 2012, The Journal of investigative dermatology.
[12] J. Ortonne,et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. , 2012, The New England journal of medicine.
[13] M. D. de Rie,et al. The pathogenesis of psoriasis: immunological facts and speculations. , 1999, Immunology today.
[14] R. Clark. Skin-resident T cells: the ups and downs of on site immunity. , 2010, The Journal of investigative dermatology.
[15] A. Bowcock,et al. PSORS2 is due to mutations in CARD14. , 2012, American Journal of Human Genetics.
[16] F. Nestle,et al. The multitasking organ: recent insights into skin immune function. , 2011, Immunity.
[17] Hong-Wei Sun,et al. Homeostatic Tissue Responses in Skin Biopsies from NOMID Patients with Constitutive Overproduction of IL-1β , 2012, PloS one.
[18] K. Duffin,et al. Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association. , 2009, The Journal of investigative dermatology.
[19] K. Peris,et al. The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans , 2011, PloS one.
[20] James T. Elder,et al. Induction of IL-17+ T Cell Trafficking and Development by IFN-γ: Mechanism and Pathological Relevance in Psoriasis1 , 2008, The Journal of Immunology.
[21] A. Bowcock,et al. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. , 2004, Trends in immunology.
[22] Andrew Blauvelt,et al. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. , 2009, The Journal of investigative dermatology.
[23] H. Soto,et al. CCL27–CCR10 interactions regulate T cell–mediated skin inflammation , 2002, Nature Medicine.
[24] M. Gilliet,et al. Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8 , 2009, The Journal of experimental medicine.
[25] J. Knight,et al. Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases , 2012, Front. Immun..
[26] T. Ganz,et al. Wound Healing and Expression of Antimicrobial Peptides/Polypeptides in Human Keratinocytes, a Consequence of Common Growth Factors1 , 2003, The Journal of Immunology.
[27] R. Steinman,et al. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. , 2007, The Journal of clinical investigation.
[28] S. Lenna,et al. Interferon‐γ promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)‐1 and transforming growth factor (TGF) β2 , 2013, Journal of cellular physiology.
[29] P. Rod Dunbar,et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens , 2010, The Journal of experimental medicine.
[30] T. Mcclanahan,et al. Cutting Edge: A Critical Functional Role for IL-23 in Psoriasis , 2010, The Journal of Immunology.
[31] Y. Simoni,et al. Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? , 2013, Clinical and experimental immunology.
[32] Lisa C. Zaba,et al. Th17 cytokines interleukin (IL)‐17 and IL‐22 modulate distinct inflammatory and keratinocyte‐response pathways , 2008, The British journal of dermatology.
[33] Mayte Suárez-Fariñas,et al. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. , 2009, The Journal of allergy and clinical immunology.
[34] James T. Elder,et al. Lack of evidence for activation of the hedgehog pathway in psoriasis. , 2009, The Journal of investigative dermatology.
[35] F. Ginhoux,et al. Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation , 2009, The Journal of experimental medicine.
[36] V. Soumelis,et al. Characterization of resident and migratory dendritic cells in human lymph nodes , 2012, The Journal of experimental medicine.
[37] N. Romani,et al. Changing views of the role of Langerhans cells. , 2012, The Journal of investigative dermatology.
[38] James T. Elder,et al. Identification of fifteen new psoriasis susceptibility loci highlights the role of innate immunity , 2012, Nature Genetics.
[39] P. Dunbar,et al. Cutting Edge: CD1a+ Antigen-Presenting Cells in Human Dermis Respond Rapidly to CCR7 Ligands1 , 2006, The Journal of Immunology.
[40] James T. Elder,et al. Mouse models of psoriasis. , 2007, The Journal of investigative dermatology.
[41] M. Suárez-Fariñas,et al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. , 2013, The Journal of allergy and clinical immunology.
[42] Subhashis Banerjee,et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. , 2012, The New England journal of medicine.
[43] H. Ueno,et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. , 2008, Immunity.
[44] J. Gelfand,et al. Psoriasis and metabolic disease: epidemiology and pathophysiology , 2008, Current opinion in rheumatology.
[45] M. Blumenberg,et al. Effects of Tumor Necrosis Factor-α (TNFα) in Epidermal Keratinocytes Revealed Using Global Transcriptional Profiling* , 2004, Journal of Biological Chemistry.
[46] S. Chimenti,et al. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. , 2011, The Journal of investigative dermatology.
[47] C. Thompson,et al. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. , 1993, Journal of immunology.
[48] B. Nickoloff,et al. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin , 1989, The British journal of dermatology.
[49] A. Smahi,et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. , 2011, The New England journal of medicine.
[50] J. Carucci,et al. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production , 2009, Proceedings of the National Academy of Sciences.
[51] V. Poli,et al. IL-6, IL-17 and STAT3: a holy trinity in auto-immunity? , 2012, Frontiers in bioscience.
[52] R. Clark,et al. The Vast Majority of CLA+ T Cells Are Resident in Normal Skin1 , 2006, The Journal of Immunology.
[53] C. Weaver,et al. Autoimmunity: increasing suspects in the CD4+ T cell lineup , 2010, Nature Immunology.
[54] I. Mellman,et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide , 2007, Nature.
[55] N. Copeland,et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[56] J. Farber,et al. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. , 2009, The Journal of clinical investigation.
[57] S. Porcelli,et al. Overexpression of CD1d by Keratinocytes in Psoriasis and CD1d-Dependent IFN-γ Production by NK-T Cells1 , 2000, The Journal of Immunology.
[58] M. Suárez-Fariñas,et al. A single intradermal injection of IFN-γ induces an inflammatory state in both non-lesional psoriatic and healthy skin , 2011, The Journal of investigative dermatology.
[59] S. Amigorena,et al. Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ–resident dendritic cells , 2013, The Journal of experimental medicine.
[60] O. Joffre,et al. Cross-presentation by dendritic cells , 2012, Nature Reviews Immunology.
[61] Dong Yu,et al. A Toll-like receptor 7, 8, and 9 antagonist inhibits Th1 and Th17 responses and inflammasome activation in a model of IL-23-induced psoriasis. , 2013, The Journal of investigative dermatology.
[62] M. Meurer,et al. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products , 1994, European journal of immunology.
[63] J. Prinz,et al. Analysis of the Paired TCR α- and β-chains of Single Human T Cells , 2012, PloS one.
[64] L. Austin,et al. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry. , 2000, Journal of autoimmunity.
[65] N. Morar,et al. The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. , 2007, The American journal of pathology.
[66] M. Simpson,et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. , 2011, American journal of human genetics.
[67] A. Bowcock. The genetics of psoriasis and autoimmunity. , 2005, Annual review of genomics and human genetics.
[68] K. Schäkel,et al. Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses. , 2011, The Journal of allergy and clinical immunology.
[69] James T. Elder,et al. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. , 2012, American journal of human genetics.
[70] K. Wittkowski,et al. Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis , 2007, Journal of Translational Medicine.
[71] F. Nestle,et al. From classical mouse models of psoriasis to a spontaneous xenograft model featuring use of AGR mice. , 2005, Ernst Schering Research Foundation workshop.
[72] J. Krueger,et al. Anti-cytokine therapies for psoriasis. , 2011, Experimental cell research.
[73] R. Arbeit,et al. Suppression of Molecular Inflammatory Pathways by Toll-Like Receptor 7, 8, and 9 Antagonists in a Model of IL-23-Induced Skin Inflammation , 2013, PloS one.
[74] M. Lebwohl,et al. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. , 1999, The Journal of clinical investigation.
[75] Hideki Fujita,et al. Combined Use of Laser Capture Microdissection and cDNA Microarray Analysis Identifies Locally Expressed Disease-Related Genes in Focal Regions of Psoriasis Vulgaris Skin Lesions , 2012, The Journal of investigative dermatology.
[76] N. J. Eungdamrong,et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. , 2009, The Journal of investigative dermatology.
[77] F. Nestle,et al. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. , 1994, The Journal of clinical investigation.
[78] Andrew Johnston,et al. Genome-Wide Expression Profiling of Five Mouse Models Identifies Similarities and Differences with Human Psoriasis , 2011, PloS one.
[79] S. Sa,et al. The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis , 2007, The Journal of Immunology.
[80] David A. Martin,et al. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. , 2013, Trends in immunology.
[81] J. Bos,et al. Immunocompetent cells in psoriasis , 1983, Archives of Dermatological Research.
[82] M. Suárez-Fariñas,et al. Gene profiling of narrowband UVB-induced skin injury defines cellular and molecular innate immune responses. , 2013, The Journal of investigative dermatology.
[83] James G. Krueger,et al. Pathogenesis and therapy of psoriasis , 2007, Nature.
[84] V. Jala,et al. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. , 2011, Immunity.
[85] J. Buckner. Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases , 2010, Nature Reviews Immunology.
[86] J. Brown,et al. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. , 1997, The Journal of clinical investigation.
[87] Elizabeth J Horn,et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. , 2008, Journal of the American Academy of Dermatology.
[88] Frank O. Nestle,et al. Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-α , 2004, The Journal of experimental medicine.
[89] V. Soumelis,et al. Human inflammatory dendritic cells induce Th17 cell differentiation. , 2013, Immunity.
[90] Andrea B Troxel,et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. , 2010, European heart journal.
[91] C. Baecher-Allan,et al. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. , 2012, Immunity.
[92] Mayte Suárez-Fariñas,et al. Evaluation of the Psoriasis Transcriptome across Different Studies by Gene Set Enrichment Analysis (GSEA) , 2010, PloS one.
[93] A. Gottlieb,et al. Differential Expression of Phosphorylated NF-κB/RelA in Normal and Psoriatic Epidermis and Downregulation of NF-κB in Response to Treatment with Etanercept , 2005 .
[94] J. Krueger,et al. Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: Gene regulation and cellular effects. , 2006, The Journal of investigative dermatology.
[95] E. Pamer,et al. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. , 2003, Immunity.
[96] D. Salinger,et al. Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial. , 2012, The Journal of investigative dermatology.
[97] T. McCormick,et al. Regulation generation: the suppressive functions of human regulatory T cells. , 2012, Critical reviews in immunology.
[98] C. Gardiner,et al. NK Cells and Psoriasis , 2011, Journal of biomedicine & biotechnology.
[99] N. J. Eungdamrong,et al. Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis. , 2010, The Journal of allergy and clinical immunology.
[100] Suyan Tian,et al. Meta-Analysis Derived (MAD) Transcriptome of Psoriasis Defines the “Core” Pathogenesis of Disease , 2012, PloS one.
[101] K. Asadullah,et al. IL-22 increases the innate immunity of tissues. , 2004, Immunity.
[102] W. Boehncke,et al. The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity , 2011, Experimental dermatology.
[103] Zihua Hu,et al. Identification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes* , 2006, Journal of Biological Chemistry.
[104] K. Wittkowski,et al. Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[105] S. Chimenti,et al. Identical TCR β-Chain Rearrangements in Streptococcal Angina and Skin Lesions of Patients with Psoriasis Vulgaris1 , 2006, The Journal of Immunology.
[106] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[107] Sarah L. Gaffen,et al. Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members* , 2004, Journal of Biological Chemistry.
[108] T. K. van den Berg,et al. The macrophage scavenger receptor CD163. , 2005, Immunobiology.
[109] V. Kumar,et al. Neutrophils: Cinderella of innate immune system. , 2010, International immunopharmacology.
[110] S. Durham,et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. , 2009, The Journal of clinical investigation.
[111] A. Hayday,et al. Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis , 2011, The Journal of Immunology.
[112] Shyamasree Datta,et al. IL-17 Regulates CXCL1 mRNA Stability via an AUUUA/Tristetraprolin-Independent Sequence , 2009, The Journal of Immunology.
[113] L. Boon,et al. Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1 , 2009, The Journal of Immunology.
[114] Luis Puig,et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. , 2010, The Journal of investigative dermatology.
[115] James T. Elder,et al. Heterogeneity of Inflammatory and Cytokine Networks in Chronic Plaque Psoriasis , 2012, PloS one.
[116] J. Streilein. Skin-associated lymphoid tissues (SALT): origins and functions. , 1983, The Journal of investigative dermatology.
[117] N. A. Abdel Fattah,et al. Tissue and blood superoxide dismutase activities and malondialdehyde levels in different clinical severities of acne vulgaris , 2008, The British journal of dermatology.
[118] S. Chimenti,et al. Allele-specific cytokine responses at the HLA-C locus, implications for psoriasis , 2011, The Journal of investigative dermatology.
[119] O. Boyman,et al. α1β1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis , 2007, Nature Medicine.
[120] R. Steinman,et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[121] M. Suárez-Fariñas,et al. Human keratinocytes' response to injury upregulates CCL20 and other genes linking innate and adaptive immunity , 2011, The Journal of investigative dermatology.
[122] D. Carlo,et al. Persistence of T-cell clones in psoriatic lesions. , 1997, Archives of dermatology.
[123] James G. Krueger,et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis , 1995, Nature Genetics.
[124] Lisa C. Zaba,et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. , 2008, The Journal of investigative dermatology.
[125] J. Gudjonsson,et al. Psoriasis--as an autoimmune disease caused by molecular mimicry. , 2009, Trends in immunology.
[126] P. Haslett,et al. IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. , 2012, The Journal of allergy and clinical immunology.
[127] Frank O. Nestle,et al. Skin immune sentinels in health and disease , 2009, Nature Reviews Immunology.
[128] E. Wagner,et al. Psoriasis: what we have learned from mouse models , 2010, Nature Reviews Rheumatology.
[129] R. Gallo,et al. Antimicrobial peptides in the pathogenesis of psoriasis , 2012, The Journal of dermatology.
[130] Y. Liu,et al. Dendritic Cell Subsets and Lineages, and Their Functions in Innate and Adaptive Immunity , 2001, Cell.
[131] Lisa C. Zaba,et al. A subpopulation of CD163-positive macrophages is classically activated in psoriasis. , 2010, The Journal of investigative dermatology.
[132] Pilar Romero,et al. IL‐17‐producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17‐related cytokines , 2009, Journal of leukocyte biology.
[133] T. Takai. Expression : Cellular Sources , Triggers , and Regulatory Mechanisms , 2010 .